Siderophore conjugates

Clinically Relevant Gram-Negative Resistance Mechanisms Have No Effect on the Efficacy of MC-1, a Novel Siderophore-Conjugated Monocarbam

(2012) Craig J. McPherson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers

(2012) Cheng Ji et al.   BIOORGANIC & MEDICINAL CHEMISTRY

In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii

(2012) P. G. Higgins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In VitroandIn VivoProperties of BAL30376, a β-Lactam and Dual β-Lactamase Inhibitor Combination with Enhanced Activity against Gram-Negative Bacilli That Express Multiple β-Lactamases

(2011) Malcolm G. P. Page et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of BAL30072 against Burkholderia pseudomallei

(2011) Takehiko Mima et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii

(2011) T. A. Russo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Distinctive Attributes of β-Lactam Target Proteins inAcinetobacter baumanniiRelevant to Development of New Antibiotics

(2011) Seungil Han et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Synthesis and biological properties of conjugates between fluoroquinolones and a N3′′-functionalized pyochelin

(2011) Sabrina Noël et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Mechanism of Bactericidal Activity of Microcin L inEscherichia coliandSalmonella enterica

(2010) Natacha Morin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli

(2010) M. G. P. Page et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Yersiniabactin Transport System Is Critical for the Pathogenesis of Bubonic and Pneumonic Plague

(2010) J. D. Fetherston et al.   INFECTION AND IMMUNITY

Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms

(2010) D. M. Livermore et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa

(2010) S. Han et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Susceptibility of Pseudomonas aeruginosa to catechol-substituted cephalosporin is unrelated to the pyochelin–Fe transporter FptA

(2009) Françoise Hoegy et al.   AMINO ACIDS

Isolation and Characterization of Two Members of the Siderophore-Microcin Family, Microcins M and H47

(2009) G. Vassiliadis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Siderophores as drug delivery agents: application of the “Trojan Horse” strategy

(2009) Ute Möllmann et al.   BIOMETALS

Sideromycins: tools and antibiotics

(2009) Volkmar Braun et al.   BIOMETALS

Synthesis of citrate–ciprofloxacin conjugates

(2009) Siti R Md-Saleh et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters

(2009) S. Mushtaq et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY